NDC 49884-148

Dexlansoprazole

Dexlansoprazole

Dexlansoprazole is a Oral Capsule, Delayed Release in the Human Prescription Drug category. It is labeled and distributed by Par Pharmaceutical, Inc.. The primary component is Dexlansoprazole.

Product ID49884-148_4d67a5db-727c-40dc-b983-504308119926
NDC49884-148
Product TypeHuman Prescription Drug
Proprietary NameDexlansoprazole
Generic NameDexlansoprazole
Dosage FormCapsule, Delayed Release
Route of AdministrationORAL
Marketing Start Date2022-11-22
Marketing CategoryANDA /
Application NumberANDA202294
Labeler NamePar Pharmaceutical, Inc.
Substance NameDEXLANSOPRAZOLE
Active Ingredient Strength60 mg/1
Pharm ClassesProton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 49884-148-09

90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (49884-148-09)
Marketing Start Date2022-11-22
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Dexlansoprazole" or generic name "Dexlansoprazole"

NDCBrand NameGeneric Name
24979-703Dexlansoprazoledexlansoprazole
24979-704Dexlansoprazoledexlansoprazole
49884-148DexlansoprazoleDexlansoprazole
50090-5944Dexlansoprazoledexlansoprazole
50090-5956Dexlansoprazoledexlansoprazole
50090-4374Dexilantdexlansoprazole
55154-5154Dexilantdexlansoprazole
64764-171Dexilantdexlansoprazole
64764-175Dexilantdexlansoprazole

© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.